Home › Neuroblastoma › Ohio › Columbus
Neuroblastoma clinical trials in Columbus, OH
5 studies for Neuroblastoma are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Nationwide Children's Hospital, Columbus
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Nationwide Children's Hospital, Columbus
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
RecruitingPhase 2
- Nationwide Children's Hospital, Columbus
Neuroblastoma Biology Study
RecruitingObservational study
- Nationwide Children's Hospital, Columbus
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RecruitingPhase 2
- Nationwide Children's Hospital, Columbus
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- Washington, DC11 studies
- New York City, NY10 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
- Philadelphia, PA9 studies
- Memphis, TN9 studies
- Hartford, CT8 studies
- Minneapolis, MN8 studies
- Birmingham, AL8 studies
- Aurora, CO8 studies
- Houston, TX7 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer54 studies
- Cancer (all types)39 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Metastatic Cancer26 studies
- Endometrial Cancer26 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
- Colorectal Cancer23 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.